Research Paper Volume 15, Issue 23 pp 13710—13737
A glycosylation-related signature predicts survival in pancreatic cancer
Figure 9. Comparisons of clinical characteristics between 3 GRGs. Age (A), gender (B), clinical grade (C), clinical stage (D), T staging (E), N staging (F), M staging (G), chemotherapy history (H), and radiotherapy history (I) of high and low SEL1L/TUBA1C/SDC1 expression groups.